This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here. This week, I published a story about the results of a study on Parkinson’s disease in which a biotech company transplanted dopamine-making neurons into people’s brains.…
